Friday, 27 January 2012

POSITIVE CONTRAST MATERIAL: IODINATED


Conventional ionic contrast media

  • diatrizoate, iothalamate, metrizoate
  • monomeric salts of tri-iodinated benzoic acid with substituted side-chains at positions 3 and 5; iodine atoms at 2,4 and 6; cation at position 1.
  • anion is the radiopaque portion but both the anion and cation are osmotically active therefore the solution will be hypertonic to plasma
    • could be made isotonic to plasma but at this dilution the iodine concentration would be only 6% and not useful as contrast agent
  • Side effects from ionic contrast agents
    • Hypertonicity
      • Main reason for side effects - 5-8x tonicity of plasma - severe physical insult to body regardless of the nature of the chemical injected.
      • endothelial lesions in blood vessels - desiccation and weakening to intracellular bonding, increased capillary permeability and risk of thrombus formation
      • damage to BBB: increased permeability of cerebral capillaries results in toxic molecules affecting nerve cells
      • RBC/blood flow: water drawn from RBC which becomes deformed and rigid and may not be able to pass through capillary beds - can cause thrombosis/ischemia esp. in brain and myocardium
      • cardiovascular effects: vasodilation both local and generalized
        • local effects: flushing, sensation of warmth, discomfort
        • generalized: hypotension
        • in man, the effects are directly proportional to the tonicity
        • problems may be greater in patients with congestive heart failure
      • renal effects: diuresis usually induced in most patients after IV injection due to increase in serum osmolality
        • acute renal failure is unusual but well recognized complication of these agents. Probably due to hypertonicity and direct chemical toxicity to kidney
        • predisposing factors: renal insufficiency, dehydration, congestive heart failure, diabetes mellitus, multiple myeloma
      • side effects (human descriptions): nausea, vomiting, fever, chills, faintness, headache, sneezing, perineal discomfort, metallic taste
    • Ionic charge
      • effects on local electrolyte balance
      • effect nerve conduction
      • cardiac effect (esp. from high sodium load)
    • Chemical toxicity
      • inherently toxic molecule, esp. the sodium salt - cardiac, hepatic, and renal disease patients are esp. susceptible to increases in sodium
      • peripheral vasodilation and other side effects are increased when the sodium concentration increases
      • methylglucamine (meglumine) salt is less toxic but has increased viscosity which is why the two are often mixed to reach a compromise between toxicity and viscosity
      • occasional toxicity found from iodinated anion or free I released
      • toxicity may occur from protein binding - esp. enzyme binding
        • acetylcholinesterase inhibition is measured as an indicator of toxicity
      • toxicity inversely proportional to degree of hydrophilia and in conventional agents the highly hydrophobic iodine atoms are relatively exposed due to short side chains
      • most sensitive organs are heart, brain and kidney
      • effect on BBB from sodium cation and carboxyl group of the anion as well as hypertonicity
        • acute tubular necrosis can occur
        • cardiotoxicity can be fatal
    • Allergic/Anaphylactic reactions
      • In humans, about 5% have some hypersensitivity reaction in minutes or delayed by hours.
      • Mechanism unknown but increased reactions in allergic or asthmatic people and those with heart disease
      • reactions range from sneezing - urticaria - pharyngeal - cerebral - or pulmonary edema - bronchospasm - to fatal cardiovascular collapse
      • in man - 1/40,000 fatality rate
      •  
       
  • Low osmolar, non-ionic contrast media

    • metrizamide, iopamidol, iohexol
    • tri-iodinated substituted ring compound - do not dissociate in solution so that hypertonicity is avoided. Side chains have been altered to make molecule highly hydrophilic to increase solubility without dissociation
    • Increased ratio of iodine per osmotic particle (3:2 for ionic) vs (3:1 for non-ionic)
      • osmolality halved (non-ionic)
      • actually reduced further by tendency for molecules to aggregate in solution
      • results in osmolality 1/3 of ionic contrast media and decreased side effects
    • Can be used for intravenous or intrathecal injections but due to expense (about 10x ionic) usually reserved for myelography
    • Image quality depends on iodine concentration and total iodine delivered
      • clarity/definition requires accumulation of contrast agent
      • osmotic dilution of the low osmolar agents by body fluids is much less and occurs more slowly than with hyperosmolar agents resulting in sharper images for longer times
     
  • Advantages of non-ionic vs ionic contrast agents

    • Reduced tonicity: since most side effects are related to hypertonicity, the change to nearly isotonic has significantly decreased reactions in man - some studies report dramatic decrease in side effects and discomfort largely due to reduction in vasodilation and resultant sensations of heat and flushing
    • Myelography: cannot use ionic contrast media for myelogrpahy so discovery of non-ionic in 1974 (metrizamide) revolutionized this procedure. Newer agents (iopamidol and iohexol) have even lower neurotoxicity
    • Chemical toxicity: molecules are more hydrophilic due to longer sidechains, shields the hydrophobic I atoms, no sodium ions, decreased damage to BBB. Increased hydrophilia means less tendency to cross cell membranes
    • Decreased hypersensitivity reactions: fatal reactions in man reported - 1/80,000 - probably most from decreased osmolality and decreased cardiotoxicity

    Fig. 2.    The a, osmolality (mOsm/kg water) and b, viscosity at 37 °C of currently available iodinated contrast media. The values in the bars show the iodine content (mg/mL). The ionic HO media are shown in green, the ionic LO medium in red, the non-ionic LO media in light green and non-ionic iso-osmolar media in light red.

     
    Thomsen, H.S. & Morcos, S.K. (2000)
    Radiographic contrast media.
    BJU International 86 (s1), 1-10.
    Available from: http://dx.doi.org/10.1046/j.1464-410x.2000.00586.x
     
    Top
     


No comments:

Post a Comment